• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部复发后与乳腺癌死亡相关的因素。

Factors associated with breast cancer mortality after local recurrence.

机构信息

Department of Medical Oncology, Sunnybrook Odette Cancer Centre and University of Toronto, ON.

Women's College Research Institute, Women's College Hospital and University of Toronto, Toronto, ON.

出版信息

Curr Oncol. 2014 Jun;21(3):e418-25. doi: 10.3747/co.21.1563.

DOI:10.3747/co.21.1563
PMID:24940101
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4059805/
Abstract

PURPOSE

We aimed to identify risk factors for mortality after local recurrence in women treated for invasive breast cancer with breast-conserving surgery.

EXPERIMENTAL DESIGN

Our prospective cohort study included 267 women who were treated with breast-conserving surgery at Women's College Hospital from 1987 to 1997 and who later developed local recurrence. Clinical information and tumour receptor status were abstracted from medical records and pathology reports. Patients were followed from the date of local recurrence until death or last follow-up. Survival analysis used a Cox proportional hazards model.

RESULTS

Among the 267 women with a local recurrence, 97 (36.3%) died of breast cancer within 10 years (on average 2.6 years after the local recurrence). The actuarial risk of death was 46.1% at 10 years from recurrence. In a multivariable model, predictors of death included short time from diagnosis to recurrence [hazard ratio (hr) for <5 years compared with ≥10 years: 3.40; 95% confidence interval (ci): 1.04 to 11.1; p = 0.04], progesterone receptor positivity (hr: 0.35; 95% ci: 0.23 to 0.54; p < 0.001), lymph node positivity (hr: 2.1; 95% ci: 1.4 to 3.3; p = 0.001), and age at local recurrence (hr for age >45 compared with age ≤45 years: 0.61; 95% ci: 0.38 to 0.95; p = 0.03).

CONCLUSIONS

The risk of death after local recurrence varies widely. Risk factors for death after local recurrence include node positivity, progesterone receptor negativity, young age at recurrence, and short time from diagnosis to recurrence.

摘要

目的

我们旨在确定接受保乳手术治疗浸润性乳腺癌后局部复发女性的死亡风险因素。

实验设计

我们的前瞻性队列研究纳入了 1987 年至 1997 年期间在女子学院医院接受保乳手术治疗且随后发生局部复发的 267 例女性患者。临床信息和肿瘤受体状态从病历和病理报告中提取。患者从局部复发之日起随访至死亡或末次随访。生存分析采用 Cox 比例风险模型。

结果

在 267 例局部复发的女性中,97 例(36.3%)在 10 年内死于乳腺癌(平均在局部复发后 2.6 年)。复发后 10 年的死亡风险为 46.1%。在多变量模型中,死亡的预测因素包括从诊断到复发的时间较短[与≥10 年相比,<5 年的风险比(HR)为 3.40;95%置信区间(CI):1.04 至 11.1;p=0.04]、孕激素受体阳性(HR:0.35;95%CI:0.23 至 0.54;p<0.001)、淋巴结阳性(HR:2.1;95%CI:1.4 至 3.3;p=0.001)和局部复发时的年龄(与年龄≤45 岁相比,年龄>45 岁的 HR 为 0.61;95%CI:0.38 至 0.95;p=0.03)。

结论

局部复发后死亡的风险差异很大。局部复发后死亡的风险因素包括淋巴结阳性、孕激素受体阴性、复发时年龄较小和从诊断到复发的时间较短。

相似文献

1
Factors associated with breast cancer mortality after local recurrence.局部复发后与乳腺癌死亡相关的因素。
Curr Oncol. 2014 Jun;21(3):e418-25. doi: 10.3747/co.21.1563.
2
Predictors of time to death after distant recurrence in breast cancer patients.乳腺癌远处复发后死亡时间的预测因素。
Breast Cancer Res Treat. 2019 Jan;173(2):465-474. doi: 10.1007/s10549-018-5002-9. Epub 2018 Oct 16.
3
The relationship between local recurrence and death in early-stage breast cancer.早期乳腺癌局部复发与死亡之间的关系。
Breast Cancer Res Treat. 2016 Jan;155(1):175-85. doi: 10.1007/s10549-015-3666-y. Epub 2015 Dec 28.
4
[Long-term recurrence rate and survival in different aged patients with breast cancer undergoing breast conserving therapy].[不同年龄乳腺癌患者保乳治疗后的长期复发率及生存率]
Zhonghua Wai Ke Za Zhi. 2021 Feb 1;59(2):127-133. doi: 10.3760/cma.j.cn112139-20200807-00617.
5
The prognostic effect of estrogen receptor status differs for younger versus older breast cancer patients.雌激素受体状态的预后效应在年轻和老年乳腺癌患者中有所不同。
Breast Cancer Res Treat. 2017 Sep;165(2):391-402. doi: 10.1007/s10549-017-4333-2. Epub 2017 Jun 10.
6
Survival and breast relapse in 3834 patients with T1-T2 breast cancer after conserving surgery and adjuvant treatment.3834例T1-T2期乳腺癌患者保乳手术后辅助治疗的生存情况及乳腺复发情况
Radiother Oncol. 2007 Mar;82(3):287-93. doi: 10.1016/j.radonc.2006.11.009. Epub 2006 Dec 22.
7
An international randomised controlled trial to compare TARGeted Intraoperative radioTherapy (TARGIT) with conventional postoperative radiotherapy after breast-conserving surgery for women with early-stage breast cancer (the TARGIT-A trial).一项国际随机对照试验,旨在比较早期乳腺癌女性保乳手术后靶向术中放疗(TARGIT)与传统术后放疗(TARGIT-A试验)。
Health Technol Assess. 2016 Sep;20(73):1-188. doi: 10.3310/hta20730.
8
Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer.21 基因检测复发评分与淋巴结阳性乳腺癌患者局部区域复发率的相关性。
JAMA Oncol. 2020 Apr 1;6(4):505-511. doi: 10.1001/jamaoncol.2019.5559.
9
Analysis of incidence and prognostic factors for ipsilateral breast tumour recurrence and its impact on disease-specific survival of women with node-negative breast cancer: a prospective cohort study.腋窝淋巴结阴性乳腺癌患者同侧乳腺肿瘤复发的发生率、预后因素及其对疾病特异性生存影响的分析:一项前瞻性队列研究
Breast Cancer Res. 2006;8(4):R44. doi: 10.1186/bcr1531.
10
Breast-cancer subtype, age, and lymph node status as predictors of local recurrence following breast-conserving therapy.乳腺癌亚型、年龄及淋巴结状态作为保乳治疗后局部复发的预测因素。
Breast Cancer Res Treat. 2017 Jan;161(1):173-179. doi: 10.1007/s10549-016-4031-5. Epub 2016 Nov 3.

引用本文的文献

1
Gene expression associated with endocrine therapy resistance in estrogen receptor-positive breast cancer.雌激素受体阳性乳腺癌中与内分泌治疗耐药相关的基因表达
Sci Rep. 2025 Feb 28;15(1):7220. doi: 10.1038/s41598-025-89274-9.
2
Machine learning prediction of breast cancer local recurrence localization, and distant metastasis after local recurrences.乳腺癌局部复发定位及局部复发后远处转移的机器学习预测
Sci Rep. 2025 Feb 10;15(1):4868. doi: 10.1038/s41598-025-89339-9.
3
Mammographic Breast Density at Breast Cancer Diagnosis and Breast Cancer-Specific Survival.乳腺癌诊断时的乳腺钼靶密度与乳腺癌特异性生存
Diagnostics (Basel). 2024 Oct 25;14(21):2382. doi: 10.3390/diagnostics14212382.
4
Lipid profiling of RON and DEK-dependent signaling in breast cancer guides discovery of gene networks predictive of poor outcomes.乳腺癌中RON和DEK依赖性信号传导的脂质谱分析有助于发现预测不良预后的基因网络。
Front Oncol. 2024 Sep 16;14:1382986. doi: 10.3389/fonc.2024.1382986. eCollection 2024.
5
C188-9 reduces patient-specific primary breast cancer cells proliferation at the low, clinic-relevant concentration.C188-9 降低了低浓度下、临床相关浓度的患者特异性原发性乳腺癌细胞的增殖。
J Transl Med. 2024 Aug 22;22(1):784. doi: 10.1186/s12967-024-05542-8.
6
Using Telemedicine to Care for Patients with Breast Cancer: A Natural Quasi-Experimental Study.利用远程医疗护理乳腺癌患者:一项自然准实验研究。
J Cancer Allied Spec. 2024 Aug 16;10(2):679. doi: 10.37029/jcas.v10i2.679. eCollection 2024.
7
Do we need reshape rTNM staging system for ipsilateral breast tumor recurrence of breast cancer? A population-based, propensity score matched cohort study.我们是否需要重塑乳腺癌同侧乳房肿瘤复发的 rTNM 分期系统?一项基于人群的倾向评分匹配队列研究。
Breast Cancer Res Treat. 2024 Aug;206(3):637-651. doi: 10.1007/s10549-024-07340-8. Epub 2024 May 10.
8
Protocol of the HISTOTHERM study: assessing the response to hyperthermia and hypofractionated radiotherapy in recurrent breast cancer.HISTOTHERM研究方案:评估复发性乳腺癌对热疗和低分割放疗的反应
Front Oncol. 2023 Dec 19;13:1275222. doi: 10.3389/fonc.2023.1275222. eCollection 2023.
9
Predicting early breast cancer recurrence from histopathological images in the Carolina Breast Cancer Study.在卡罗来纳乳腺癌研究中通过组织病理学图像预测早期乳腺癌复发
NPJ Breast Cancer. 2023 Nov 11;9(1):92. doi: 10.1038/s41523-023-00597-0.
10
Anti-cancer effectiveness of a novel ceramide analog on chemo-sensitive and chemo-resistant breast cancers.新型神经酰胺类似物对化疗敏感和耐药乳腺癌的抗癌作用。
Anticancer Drugs. 2024 Jan 1;35(1):12-21. doi: 10.1097/CAD.0000000000001536. Epub 2023 Aug 15.

本文引用的文献

1
Survival in patients with metastatic recurrent breast cancer after adjuvant chemotherapy: little evidence of improvement over the past 30 years.辅助化疗后转移性复发性乳腺癌患者的生存情况:过去 30 年几乎没有改善的证据。
Cancer. 2013 Mar 15;119(6):1140-8. doi: 10.1002/cncr.27819. Epub 2012 Oct 12.
2
Breast cancer in young women.年轻女性乳腺癌。
Nat Rev Clin Oncol. 2012 Jun 26;9(8):460-70. doi: 10.1038/nrclinonc.2012.102.
3
Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy.年龄、乳腺癌亚型近似和保乳治疗后的局部复发。
J Clin Oncol. 2011 Oct 10;29(29):3885-91. doi: 10.1200/JCO.2011.36.1105. Epub 2011 Sep 6.
4
Breast cancer subtypes and outcome after local and regional relapse.乳腺癌亚型与局部和区域复发后的结局。
Ann Oncol. 2012 Feb;23(2):324-31. doi: 10.1093/annonc/mdr129. Epub 2011 Apr 27.
5
The impact of contralateral mastectomy on mortality in BRCA1 and BRCA2 mutation carriers with breast cancer.乳腺癌 BRCA1 和 BRCA2 突变携带者中对侧乳房切除术对死亡率的影响。
Breast Cancer Res Treat. 2011 Jul;128(2):581-3. doi: 10.1007/s10549-011-1479-1. Epub 2011 Apr 1.
6
Local recurrence after breast cancer affects specific survival differently according to patient age.乳腺癌局部复发会根据患者年龄的不同而对特定生存产生不同的影响。
Oncology. 2010;79(5-6):349-54. doi: 10.1159/000323483. Epub 2011 Mar 23.
7
Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning.保乳治疗后同侧乳房肿瘤复发的分类可以预测患者的预后,并有助于治疗计划的制定。
Ann Surg. 2011 Mar;253(3):572-9. doi: 10.1097/SLA.0b013e318208fc2a.
8
Breast cancer subtypes and the risk of local and regional relapse.乳腺癌亚型与局部和区域复发的风险。
J Clin Oncol. 2010 Apr 1;28(10):1684-91. doi: 10.1200/JCO.2009.24.9284. Epub 2010 Mar 1.
9
Efficient reduction of loco-regional recurrences but no effect on mortality twenty years after postmastectomy radiation in premenopausal women with stage II breast cancer - a randomized trial from the South Sweden Breast Cancer Group.保乳术后放疗对绝经前 II 期乳腺癌患者 20 年局部区域复发的有效降低作用,但对死亡率无影响——来自瑞典南部乳腺癌研究组的一项随机试验。
Breast. 2009 Oct;18(5):309-15. doi: 10.1016/j.breast.2009.09.006. Epub 2009 Oct 6.
10
Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel.使用五生物标志物组合预测早期浸润性乳腺癌保乳治疗后的局部复发、远处转移和死亡情况。
J Clin Oncol. 2009 Oct 1;27(28):4701-8. doi: 10.1200/JCO.2008.21.7075. Epub 2009 Aug 31.